Skip to main content
Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
39.77
+0.09 (0.23%)
At close: Mar 9, 2026, 4:00 PM EDT
39.43
-0.34 (-0.85%)
After-hours: Mar 9, 2026, 6:40 PM EDT

Soleno Therapeutics Revenue

In the year 2025, Soleno Therapeutics had annual revenue of $190.41M. Soleno Therapeutics had revenue of $91.73M in the quarter ending December 31, 2025.

Revenue (ttm)
$190.41M
Revenue Growth
n/a
P/S Ratio
10.78
Revenue / Employee
$1,046,181
Employees
182
Market Cap
2.05B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025190.41M--
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Galapagos NV 1.31B
Ultragenyx Pharmaceutical 673.00M
Iovance Biotherapeutics 263.50M
Stoke Therapeutics 205.63M
Syndax Pharmaceuticals 172.35M
Mesoblast 65.38M
Nektar Therapeutics 62.60M
Ascentage Pharma Group International 54.52M
Revenue Rankings

SLNO News

More News